▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Jon Younkman

GreystoneCap

Recent Articles by Jon Younkman

cloud computing getty 6.2.17

Jan 31, 2020 by Jon Younkman

IBM Returns To Revenue Growth, But Is It Sustainable?

Six months post the Red Hat acquisition, was the $34 billion well spent?

clothes shopping woman retail

Dec 31, 2019 by Jon Younkman

Near Historic Lows, Is Macy's Stock A Present For Investors Or Just Coal?

There’s a 75%-off sale on Macy’s stock. Is this a going out of business sale?

research scientists drugs pharma biotech

Dec 16, 2019 by Jon Younkman

Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?

Will this pharmaceutical giant be able to grow through Celgene’s patent cliff? Perhaps not, but it's still worth an investment.

hypodermic needles syringe drug pharma

Dec 16, 2019 by Jon Younkman

Is AbbVie’s Dividend Capable Of Long-Term Growth?

This pharmaceutical giant is a victim of its own success. Will an $86 billion acquisition stave off its impending patent cliff?

GettyImages-1088950364

Nov 25, 2019 by Jon Younkman

Is Cisco Systems Still On The Right Route?

The networking gear giant released disappointing guidance. Is this weak outlook an industry phenomenon or is it more company-specific?

GettyImages-992892492

Nov 25, 2019 by Jon Younkman

IBM Has Its Head In The Clouds

Is the recent closing of the Red Hat acquisition reaccelerating Big Blue’s growth?

GettyImages-505798602

Nov 25, 2019 by Jon Younkman

Looking Through The Smoke To Altria’s Future

Altria remains strong despite tobacco industry transformation.

warner

Nov 18, 2019 by Jon Younkman

This Wireless Carrier Is T’d Up for Growth

AT&T's latest earnings report and the unveiling of HBO Max should reassure investors this behemoth is heading in the right direction.

GettyImages-1126056137

Nov 12, 2019 by Jon Younkman

Altria Has a Juul in the Rough

The hysteria surrounding the vaping industry has neared its apogee and the overreaction will soon correct itself.

GettyImages-988625072

Nov 5, 2019 by Jon Younkman

With the Altria Deal Dead, the Smoke Is Clearing at Philip Morris

The potential merger between cigarette makers has been called off. So how does Philip Morris stand alone as an investment?

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services